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ABSTRACT
EPITHELIAL RESPONSES TO PORPHYROMONAS GINGIVALIS IN THE COMMUNITY
CONTEXT
Zackary Ray Fitzsimonds
July 14, 2020
Porphyromonas gingivalis, a keystone pathogen for periodontal disease, initiates
a complex molecular dialogue with gingival epithelial cells, leading ultimately to
disruption of host signaling pathways. Dysbiotic host responses are also thought to
contribute to the initiation and progression of oral squamous cell carcinomas. Recently,
the homeostatic commensal Streptococcus gordonii has been shown to antagonize P.
gingivalis-induced epithelial cell signaling events in host cells, such as proliferation and
migration. The aim of this study was to characterize pathways that P. gingivalis targets to
disturb host signaling, with a specific focus on pathways that S. gordonii can restore to
homeostatic levels in the presence of P. gingivalis. RNAseq analysis of gingival epithelial
cells challenged with P. gingivalis revealed a transcriptional pattern reflecting activation
of Notch signaling. Signaling is activated by proteolytic cleavage of Notch and Jag1 by
gingipain proteases and leads to upregulation of Olfactomedin 4 (OLFM4). This activation
is antagonized by S. gordonii through the secretion of hydrogen peroxide, which
inactivates the gingipains, preventing proteolytic cleavage of Notch1 and Jag1, ultimately
blocking OLFM4 upregulation. OLFM4 is required for P. gingivalis-induced epithelial cell
iv

migration. RNAseq analysis identified an OLFM4-independent immune signature that
included increased expression of CXCL8, CXCL10, and CXCL11 in epithelial cells
transfected with siRNA and then challenged with P. gingivalis. In addition, a tissue culture
model revealed that OLFM4 was required for P. gingivalis-induced epithelial cell
migration. OLFM4 therefore represents a new axis by which P. gingivalis disturbs
homeostasis at the mucosal barrier, as well as an additional mechanism for ameliorating
this disruption by S. gordonii. This study provides insight into the complex molecular
dialogue at the mucosal-microbe interface, and as a result expands on the need for new
therapeutic approaches to prevent and identify those at high-risk for oral squamous cell
carcinoma.

v

TABLE OF CONTENTS
Page
Acknowledgements ........................................................................................................... iii
Abstract ............................................................................................................................. iv
List of Figures .................................................................................................................... vii
Chapter 1 Introduction ........................................................................................................ 1
Chapter 2 Materials and Methods ..................................................................................... 22
Chapter 3 Results ............................................................................................................... 31
Chapter 4 Discussion .......................................................................................................... 63
References .......................................................................................................................... 74
Curriculum Vitae ................................................................................................................. 83

vi

LIST OF FIGURES
Figure

Page

1. Summary of P. gingivalis virulence factors involved in host signaling manipulation
and their targets ........................................................................................................... 4
2. Potential mechanisms by which P. gingivalis could impact cancer associated
processes in gingival epithelial cells ............................................................................. 7
3. Schematic representation of polymicrobial synergy and dysbiosis model for oral
squamous cell carcinoma ........................................................................................... 20
4. Antagonistic interactions of S. gordonii on P. gingivalis through activation of the
TAK1-NLK host kinase cascade ................................................................................... 22
5. RNAseq of TIGK cells challenged with P. gingivalis and/or S. gordonii....................... 37
6. Regulation of OLFM4 by P. gingivalis ......................................................................... 39
7. Regulation of Notch signaling by P. gingivalis ............................................................ 42
8. P. gingivalis induces paracrine activation of Notch signaling through soluble
Jagged1 ....................................................................................................................... 43
9. Wnt/β-catenin and ZEB2 are not required for activation of OLFM4 by P. gingivalis . 45
10. SMAD3 enhances upregulation of Jagged1 by P. gingivalis ....................................... 46
11. Activation of Notch signaling by P. gingivalis gingipains ............................................ 48
12. Antagonism of P. gingivalis induced OLFM4 by S. gordonii ........................................ 51
13. NLK-FOXO1 signaling is not required for inhibition of OLFM4 ................................... 54
vii

14. S. gordonii cannot inhibit Notch signaling activated with exogenous Jagged1 .......... 55
15. Inhibition of gingipains by Streptococci produced H2O2 ............................................. 56
16. Knocking down OLFM4 reveals altered inflammatory transcriptomic profile ............ 60
17. P. gingivalis promotes migration of epithelial cells through OLFM4 .......................... 61
18. Graphic summarizing the pathway by which P. gingivalis activates Notch signaling,
and OLFM4 as a downstream target of activation ..................................................... 62
19. Graphic summarizing signaling pathways manipulated by P. gingivalis..................... 70
S1. Confirmation of siRNA transfections .......................................................................... 29

viii

CHAPTER 1 INTRODUCTION
Worldwide, approximately 405,000 patients are diagnosed with oral cancer each
year with a the 5-year survival rate of just 50% [1]. This poor prognosis can be partially
explained by the characteristic asymptomatic presentation in the early stages; by the time
the patient has developed painful symptoms the carcinoma is in its late stages [2]. Oral
cancers can originate as lymphomas in the lymphatic tissue of the tonsils and base of
tongue; as carcinomas within salivary gland tissue; but most commonly as squamous cell
carcinomas in areas of the mouth containing stratified squamous epithelium. Carcinomas
of the oropharynx (including the base of the tongue) are generally referred to as
oropharyngeal squamous cell carcinomas (OPSCC), and in OPSCC human papillomavirus
(HPV) infection is a major risk factor [3]. Cancers of the oral squamous cells (OSCC), which
account for about 90% of oral carcinomas, present most frequently on the tongue, lips,
floor of the mouth, and gingiva [4]. Around 75% of OSCC can be attributed to tobacco
smoking, which increases the risk for developing oral cancer by 6-fold [2]. Smoking also
provides an encouraging environment for periodontal pathogens, and is an independent
risk factor for periodontal disease [3]. Alcohol is another significant risk factor for oral
cancer, and the combined risk for those who smoke and drink is increased fifteen-fold [2].
Gingival squamous cell carcinoma (GSCC) is particularly interesting because the
traditional risk factors of smoking and alcohol consumption are not associated with this
malignancy, and as the lesions mimic the appearance of periodontal disease they tend to
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go untreated [5]. Tooth loss as a result of bone loss in periodontal disease is an
independent risk factor for head and neck, gastric, and colorectal cancer [6, 7].
Additionally, colonization by periodontal pathogens has recently been identified as a risk
factor for OSCC independent of alcohol, smoking, and HPV [3], and increased colonization
by the periodontal pathogen Porphyromonas gingivalis has been correlated with GSCC
[8]. The association between the oral microbiota (the collection of microorganisms found
in the oral cavity) and cancers of the head and neck region has been extensively studied
in recent years, using both culture dependent and independent methodology [9,10].
What has emerged is a picture of enrichment of particular organisms such as
Fusobacterium nucleatum, Treponema denticola, and P. gingivalis, along with a decrease
in the oral streptococci (with the exception of S. anginosus) [9, 10].
The notion that bacteria may be involved in the development of oral tumors is not
new. For example Treponema pallidum was considered an etiological agent of OSCC back
in the early part of the 20th century. However, with the subsequent recognition of the
importance of viruses in carcinogenesis the idea fell in to abeyance, and it was not until
Helicobacter pylori was established as a cause of gastric cancer in the 1990s that the
potential for a carcinogenic role of bacteria became rehabilitated [11, 12].
Mechanistically, there are a number of broadly defined categories by which bacteria could
contribute to tumor growth and development. These include modulation of the balance
of host cell proliferation and death; disruption of immune surveillance; and alteration of
the metabolism of host produced compounds, nutritional substrates or pharmaceuticals
[13]. Oral bacteria such as P. gingivalis, F. nucleatum and T. denticola exhibit properties
2

consistent with these criteria, and can increase epithelial cell proliferation while inhibiting
apoptosis, alter the inflammatory microenvironment and produce carcinogenic
metabolites. These organisms will be discussed and referenced below due to their
positive correlation with OSCC, as well the availability of mechanistic studies that have
shown cancer-associated phenotypes.
Porphyromonas gingivalis
P. gingivalis is a keystone pathogen in periodontitis [14, 15] and many of the
pathogenic mechanisms that impinge upon tissue integrity and disrupt protective
immune responses are potentially relevant to tumorigenesis. These pathogenic
mechanisms are summarized in Fig. 1.
Moreover, immunohistochemistry and other detection methods have identified
increased colonization of P. gingivalis in OSCC, esophageal squamous cell carcinoma
(ESCC), and GSCC [8, 16, 17]. In vitro, P. gingivalis engages gingival epithelial cells (GECs)
in a complex molecular dialogue, a major thread of which involves subversion of host
signaling pathways by bacterial effectors, such as the FimA-component fimbriae and the
SerB serine phosphatase, to promote bacterial entry, intracellular trafficking and survival
[18-20]. Comprehensive analyses of host transcriptional response to P. gingivalis invoke
a pattern of enhanced cell survival and proliferation [21-23] phenotypes that have been
verified by a number of laboratories.

3

Figure 1: Summary of P. gingivalis virulence factors involved in host signaling
manipulation and their targets.
Indeed, P. gingivalis utilizes multiple mechanisms to suppress host cell death and
stimulate proliferation.

In primary cultures of GECs, P. gingivalis activates the

Jak1/Akt/Stat3 signaling hub that controls intrinsic mitochondrial apoptosis pathways [24,
25], and at the mitochondrial membrane the activity of proapoptotic effectors such as
Bad is reduced, while the ratio of antiapoptotic factors, such as Bcl2, to proapoptotic
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factors is increased [26]. Downstream caspases including caspase-9 and the executioner
caspase-3 are consequently suppressed.

Additionally, P. gingivalis can modulate

expression of microRNAs (miRs) in epithelial cells, and up-regulation of miR-203 leads to
reduction of the proapoptotic signaling molecule SOCS3 [27]. A major antiapoptotic
effector molecule of P. gingivalis is the secreted enzyme nucleoside diphosphate kinase
(NDK), which can function as an ATPase and prevent ATP-dependent apoptosis mediated
through the purinergic receptor P2X7 [28]. Another antiapoptotic function of NDK
involves phosphorylation of Heat-shock-protein-27 (HSP27) which curtails cytochrome C
release and caspase-9 activation [29]. Recently it has become apparent that P. gingivalis
possesses a variety of kinase and phosphatase enzymes, some of which can function
within host cells. Of particular relevance to cell survival, activation of the multi-purpose
transcriptional regulator FOXO1 by dephosphorylation of serine residues induces
antiapoptotic programs in epithelial cells, and knockdown of FOXO1 abrogates P.
gingivalis-induced resistance to cell death [30].
Along with prolonged cell survival, increased proliferation is a feature of P.
gingivalis infected epithelial cells.

Signaling induced by the FimA fimbrial protein

accelerates progression of primary GECs through the S-phase of the cell cycle by
manipulation of cyclin/CDK (cyclin-dependent kinase) activity and by reducing the level
of the p53 tumor suppressor [31]. The gingipains of P. gingivalis may also contribute to
cell proliferation through proteolytic activation of β-catenin and disassociation of the βcatenin destruction complex. The accumulation of active β-catenin fragments in the
nucleus drives the activity of the β-catenin-dependent, pro-proliferative TCF/LEF
5

promoter [32].

In oral squamous carcinoma cells, P. gingivalis can increase cell

proliferation by regulating cyclin D1 expression through the miR-21/PDCD4/AP-1 negative
feedback signaling pathway [33]. Additionally, in oral tumor cells P. gingivalis can
increase expression of α-defensins which have been found to elevate proliferation
through effects on epidermal growth factor receptor (EGFR) signaling [34].
Another role for P. gingivalis in carcinogenesis relates to its ability to influence the
epithelial to mesenchymal transition (EMT) in GECs, as shown in Fig. 2. EMT is a cellular
program through which epithelial cells shed their tight junctions in favor of an individual,
mesenchymal phenotype. EMT is important for embryogenesis, and wound healing, but,
if uncontrolled, ultimately leads to increased migration/invasion and cancer cell
stemness. As befits its importance to the cell, EMT is controlled by a complex regulatory
network involving a series of transcription factors such as Zinc Finger E-Box Binding
Homeobox 1 (ZEB1), Zinc Finger E-Box Binding Homeobox 2 (ZEB2), Snail Family
Transcriptional Repressor 1 (SNAI1), and Twist Family BHLH Transcription Factor 1
(TWIST1). These factors induce EMT by downregulating epithelial cell tight junction
proteins (e.g. E- cadherin (CDH1), Zona Occludens Protein 1 (ZO-1)) while upregulating
mesenchymal characteristics (e.g. N-cadherin (CDH2), matrix metallopeptidase (MMP) 9
Vimentin (VIM)) [17, 35-38].
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Figure 2: Potential mechanisms by which P. gingivalis (dark green rods) could impact
cancer associated processes in gingival epithelial cells. Peach healthy epithelial cells, Blue
epithelial cells that have acquired an anti-apoptotic phenotype, Purple epithelial cells that
have acquired an accelerated proliferation phenotype, and Green epithelial cells that
have undergone EMT, and have acquired an invasive phenotype. For simplicity other
contributing host and environmental factors are not depicted.
ZEB1 is upregulated in a FimA-dependent manner through a pathway that involves
GSK-3β in primary GECS [17, 37]. ZEB2, on the other hand, is regulated in a FimAindependent manner involving gingipain processing and activation of β-catenin along
with dephosphorylation and activation of FOXO1 [38]. Although the extent and duration
of EMT induced by P. gingivalis remains to be determined, epithelial cell infection leads
to an increase in stemness, as evidenced by upregulation of the stem cell markers CD44
and CD133 and enhanced migration [17, 35-38]. Invasion, and potentially metastasis of
7

epithelial cells, can be facilitated by host MMP enzymes which degrade extracellular
matrix and basement components.

P. gingivalis has been shown to upregulate

production of several MMPs including MMP-1, MMP-2, MMP-7, MMP-9 and MMP-10
from primary and transformed oral epithelial cells [17, 36, 37, 39, 40]. In invasive OSCC
lines, P. gingivalis gingipains can stimulate proteinase-activated receptor 2 (PAR2) and
PAR4 to increase MMP-9 proenzyme expression through ERK1/2-Ets1, p38/HSP27, and
NF-kB pathways [40]. Subsequently, in a two-hit mechanism, gingipains process the
proenzyme to active MMP9 ensuring an increase in cellular invasion [40, 41]
P. gingivalis has also been shown to activate Notch signaling through its secreted
gingipains. Notch signaling is another pathway that can be activated to inhibit apoptosis,
accelerate cell cycle progression, and induce EMT. Al-Attar et al. have shown that P.
gingivalis activates Notch signaling specifically through Notch1, and the triple gingipain
knockout mutant was unable to stimulate the pathway [42]. These investigators primarily
focused on Notch activation leading to secretion of PLA2-IIA, which is an anti-microbial
peptide utilized by P. gingivalis to shift to a more pathogenic microbial community [42].
While a role for P. gingivalis induced Notch signaling has been defined in terms of
anti-microbial peptide regulation, traditional Notch regulated phenotypes associated
with transformation of epithelial cells have not been characterized. Notch signaling has
also been shown to regulate Olfactomedin 4 (OLFM4), which is a secreted glycoprotein
that was first characterized by its role in inhibition of apoptosis through binding of the
mitochondrial protein GRIM19 [43]. Since that initial study, OLFM4 has been shown to
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additionally accelerate cell-cycle progression, activate EMT, positively regulate MMPs,
and dampen the innate immune response [44-47].
Liu et. al. showed that H. pylori upregulates OLFM4 in the stomach, and this
regulation allows for efficient colonization [47]. Moreover, upon deletion of OLFM4, H.
pylori was efficiently cleared by an unimpaired innate immune response. Another study
sought to characterize the secretome of non-neoplastic, immortalized epithelial cells and
neoplastic oral derived cell lines [48]. OLFM4 was the most secreted protein (12-fold
increase) in tested supernatants of neoplasm-derived cell lines compared to the
supernatant of non-neoplasm, immortalized cells, although its extracellular function has
not been characterized [48] .
Chronic inflammation has emerged as a major contributor to tumor growth and
metastasis, mainly through modulation of the tumor microenvironment by cytokines and
chemokines, and through differential receptor expression [49]. The ability of P. gingivalis
to incite prolonged, dysregulated inflammation could also contribute to the
epidemiological associations between periodontitis and OSCC [49, 50]. In both OSCC cell
lines and primary GECS P. gingivalis can upregulate programmed death-ligand 1 (PD-L1,
B7-H1) and B7-DC, receptors that lead to anergy and apoptosis of activated T cells, and
contribute to tumor cells’ resistance to host immune responses [51]. In OSCC cells P.
gingivalis stimulates the release of a variety of chemokines/cytokines including IL-8, IL-6,
TGF-β1, and TNF-α [35, 39, 52]. IL-8 can increase MMP production and cell invasiveness,
as well as stimulate proliferation through transactivation of the Epidermal growth factor
(EFG)receptor [53]. In addition, the IL-23/IL-17 axis, which is strongly pro-tumorigenic in
9

colorectal cancer [54], can be induced by P. gingivalis [55]. Interestingly, in primary GECs
P. gingivalis adopts a more stealth-like behavior through a process known as localized
immune paralysis [56]. Release of a serine phosphatase (SerB) intracellularly results in
antagonism of IL-8 production through dephosphorylation of the serine 538 residue of
the p65 subunit of NF-κB [57].

Dephosphorylation of the p65 subunit prevents

dimerization of the subunits, thus inactivating NF-κB. While this may restrain tumor
progression, the effect may be offset by inhibition of the angiostatic chemokines CXCL9,
CXCL10 and CXCL11 that would otherwise promote neovascularization of tumors and
increased tumor growth or metastasis [49, 58].
In vivo evidence also supports a role for P. gingivalis in the development of oral
carcinomas. In the 4-nitroquinoline-1-oxide (4NQO) tongue squamous cell carcinoma
model, P. gingivalis-treated mice developed more and larger tumors on the tongue
compared to the carcinogen alone group [59-62]. The development of squamous cell
carcinoma was associated with enhanced free fatty acid production both in the tongue
and in the serum of 4NQO treated mice, which is a shift also seen in oral cancer.
Fusobacterium nucleatum
While F. nucleatum is prevalent in a healthy microbiota, several studies have
found that F. nucleatum is significantly enriched in patients with disease, whether that be
periodontal disease, preterm delivery of low birth weight infants, head and neck cancer,
or colorectal cancer (CRC) [63]. The potential role of F. nucleatum in cancers has been
investigated in both in vitro and in vivo studies. F. nucleatum produces an adhesin, FadA,
which is crucial for attachment and subsequent invasion of epithelial cells [64]. FadA is
10

thought to play a major role in CRC by binding to E–cadherin on CRC cells, thus activating
β-catenin signaling and differentially regulating inflammatory and oncogenic responses
[65]. The FadA-E-cadherin axis also upregulates Annexin A1, a modulator of Wnt/βcatenin-based proliferative signaling in CRC cells [66]. Localization of what is primarily an
oral organism with developing tumors in the GI tract may be accomplished by another
fusobacterial adhesin, Fap2, which binds to Gal-GalNac, abundant on CRC cell surfaces
[67]. Fap2 can also immunosuppress tumor infiltrating lymphocytes, which are essential
for immune responses to tumors. Specifically, Fap2 binds and activates the inhibitory
immunoreceptor TIGIT which is expressed by T and Natural Killer (NK) cells [68]. Further
compromising anti-tumor immunity, F. nucleatum activates the human inhibitory
receptor CEACAM1 which also suppresses T and NK cells activities [69]. Clearly then, F.
nucleatum can significantly impact cell signaling and tumor immunity with relevance to
CRC. The extent to which these properties may pertain to OSCC is a vein of information
ready to be mined. Studies that have been performed establish the ability of F. nucleatum
to induce nuclear localization of NF-κB in GECs, while also increasing secretion of IL-1β via
activation of the NLRP3 inflammasome and caspase-1 [70]. Release of endogenous
danger-associated molecular patterns (DAMPs) such as apoptosis-associated speck-like
protein (ASC) and high-mobility group box 1 protein (HMGB1) further amplifies
inflammation. P38 is also activated by F. nucleatum, which leads to increased secretion of
MMP9 and MMP13 [71]. Moreover, F. nucleatum can induce an EMT program in OSCC
cells through upregulation of TGF-β, TNFα, and EGF signaling [35]. In conclusion, F.

11

nucleatum induces proliferation of CRC cells, suppresses T and NK cell activity, and
increases secretion of MMP9 and MMP13, all of which contribute to carcinogenesis.
Coinfection with F. nucleatum and P. gingivalis exacerbated in vivo tumor
development in the murine 4NQO tongue squamous cell carcinoma model [60]. The
infected group had larger, more invasive tumors, with increased expression of cell cycle
progression marker Cyclin D1 [60]. There was also an increase in phosphorylation of
STAT3 in the infected group, which led to increased expression of IL-6 [60]. Further, in a
colorectal cancer model F. nucleatum increases the size and number of tumors which
develop in C57Bl/6 Apcmin/+ mice [72]. In summary, F. nucleatum enhances tumorigenesis
in OSCC and CRC murine models, and with P. gingivalis is of critical importance in
understanding microbial contributions to oral carcinogenesis.
Treponema denticola
In a healthy person’s oral cavity, T. denticola is found in low abundance; however,
in periodontal disease, T. denticola is one of the most abundant organisms [73]. Similarly,
an increased abundance of T. denticola has been associated with ESCC and OSCC, and
similarly correlated with an increased risk of CRC [74]. T. denticola is highly proteolytic,
with dentilisin (chymotrypsin-like proteinase) being the primary secreted protease [75].
The presence of dentilisin is strongly correlated with early-stage mobile tongue squamous
cell carcinoma, and high expression of dentilisin is associated with increased tumor
invasion, tumor size, and recurrence in patients less than 60 years old [76]. Dentilisin can
degrade IL-8 and TNFα [77, 78], and cleaves pro-MMP8 and pro-MMP9 to their active
forms [10]. In a two-hit mechanism, dentilisin also degrades tissue inhibitors of MMPs,
12

TIMP1 and TIMP2, contributing to overall more proteolytic environment favoring invasion
of epithelial cells. To summarize the above, T. denticola is associated with ESCC, OSCC,
and CRC, and its secreted protease dentilisin is responsible for degradation of IL-8, TNFα,
TIMP1, and TIMP2, all of which could contribute to an environment capable of inducing
transformation of epithelial cells.
Oral Microbial Communities
The preceding text describes how individual species impact carcinogenesis;
however, in the oral cavity, bacteria assemble into multi-species, spatially constrained
communities known as biofilms. Within these communities, functional specialization of
bacterial species emerges, and in periodontitis it is pathogenicity at the community level,
or nososymbiocity, which is thought to determine the potential for disease [15].
Metabolic interactions can drive the spatial and temporal arrangement of organisms in
the oral polymicrobial community, and individual species tend to associate with partners
that are physiologically compatible [79]. Interestingly, a bioinformatics study of 11 oral
bacteria identified a large redundancy in the metabolic potential of the community, and
metabolic capabilities varied among early and late colonizers [80]. Furthermore, a recent
meta- transcriptomic analysis of diseased periodontal sites as compared with patient
matched healthy sites determined the metabolic profile of the community was highly
conserved, whereas individual species associated with this profile were interchangeable.
In other words, the overall metabolic profile is more consistent than the presence or
absence of individual species. These studies suggest that the overall metabolic potential
of the community may correlate better with disease than the presence of individual
13

species [81]. Overall metabolic stability is likely driven by shared ecology and stresses,
and community homeostasis is a balance between metabolic redundancy and metabolic
cross-feeding. If the metabolic capabilities and community metabolic necessities
overlapped to a large extent, this would result in constant competition among individual
species for nutrients. Instead, the conservation of core metabolic functions and
mutualistic metabolism reduces antagonistic interactions between integral community
participants and promotes community homeostasis.
Spatial Determinants Between Oral Microbes
Within a subgingival biofilm, the stable environment and intimate proximity
facilitate nutrient transfer mechanisms among microbial constituents. For example,
spatial imaging of plaque biofilms shows that Porphyromonas gingivalis and
Fusobacterium nucleatum are often in close association [82]. In addition, F. nucleatum
enhances the growth of P. gingivalis in the presence of oxygen, which suggests that the
more

aerotolerant

F.

nucleatum

consumes

oxygen,

thereby

providing

a

microenvironment with lower redox potential to benefit the growth of more oxygensensitive organisms [83].
In a study by Palmer et al. [84], Actinomyces naeslundii was incubated in minimal
medium that did not support its growth; however, it displayed robust growth and
coaggregation when cocultured with Streptococcus oralis. Streptococcus gordonii and
related mitis group streptococci participate in several instances of cooperative
metabolism. S. gordonii catabolizes carbohydrates and secretes H2O2 and L-lactate, a
major carbon source for lactate-utilizing bacteria such as Veillonella atypica and
14

Aggregatibacter actinomycetemcomitans [85, 86]. Consequently, S. gordonii and related
organisms can promote A. actinomycetemcomitans growth, biofilm formation, and in vivo
pathogenicity [87, 88]. V. atypica induces expression of the amyB gene, encoding an αamylase, of S. gordonii [89]; and thus S. gordonii grows better in association with V.
atypica and secretes more lactate due to carbohydrate utilization, to the benefit of both
organisms. Moreover, cooperative metabolism may have global benefits to other
community members, as the lactate-utilizing V. atypica and A. actinomycetemcomitans
neutralize acidification of the oral environment, thus protecting more acid-sensitive
species, such as P. gingivalis.
Metabolic Cooperation between A. actinomycetemcomitans and S. gordonii
The relationship between A. actinomycetemcomitans and S. gordonii is more
complex and involves a balance between synergistic cross-feeding and antagonistic
interactions. Stacy et al. [90] demonstrated that A. actinomycetemcomitans spatially
positions itself far enough away to allow detoxification of H2O2 through the production
of catalase, but close enough to S. gordonii to benefit from the secretion of L-lactate.
Optimal positioning of A. actinomycetemcomitans within the biofilm matrix is achieved
through the production of dispersin B, an enzyme that hydrolyzes polysaccharides and is
upregulated in the presence of S. gordonii [91]. Additionally, S. gordonii increases the
availability of oxygen for A. actinomycetemcomitans to use as a terminal electron
acceptor. In this way, S. gordonii shifts the metabolism of A. actinomycetemcomitans
from fermentative to oxidative respiration [92]. This process, termed “cross-respiration,”
also enhances the growth and fitness of A. actinomycetemcomitans. Similar homeostatic
15

mechanisms to maximize energy gains from metabolic cross-feeding, while reducing
antagonistic interactions, may represent a fundamental force in shaping the spatial
organization of dental plaque. A. actinomycetemcomitans possesses the capability to
influence global regulation of community development, and its presence in an in vitro
multispecies biofilm was shown to modulate the proteomic profile of the entire complex
community [95]. Further investigation identified the community regulator as the histonelike family of nucleoid-structuring (H-NS) proteins of A. actinomycetemcomitans. H-NS
proteins act as translational silencers with global regulatory potential in many Gramnegative bacteria. In Escherichia coli, deletion of the hns gene attenuates biofilm
development [93], similar to its role in A. actinomycetemcomitans, where it promotes
biofilm development as well as adhesin production [94]. Proteomic analysis of an in vitro
polymicrobial community with the hns deletion strain of A. actinomycetemcomitans
suggested that H-NS globally regulates community metabolic pathways involved in
peptide, carbohydrate, and malate metabolism [95].
Metabolic Cooperation Between Oral Streptococci and P. gingivalis
Oral streptococci also have a significant impact on the properties and pathogenic
potential of P. gingivalis, and these organisms are located in close proximity in vivo [82].
Interactions occur on multiple levels and many involve metabolic communication. Oral
streptococci efficiently metabolize sugars, and a reduction in galactose in the biofilm
milieu could alter physiology, cell shape, and intracellular granulation of P. gingivalis [96].
S. gordonii promotes increased biofilm development and synergistic pathogenicity in
rodent models of periodontitis with P. gingivalis [97-99]. The S. gordonii genes spxB and
16

cbe are among those instrumental in promoting biofilm development with P. gingivalis
[100]. SpxB (pyruvate oxidase) produces acetyl phosphate and H2O2 from pyruvate under
aerobic conditions, but its role in promoting biofilm development with P. gingivalis
remains unclear. Cbe (chorismate- binding enzyme) synthesizes para-aminobenzoic acid
(pABA) for secretion and folate biosynthesis. Recently, pABA was determined to promote
fitness and colonization of P. gingivalis in vivo with a mouse oral model [101]. Moreover,
pABA reduced the overall stress of P. gingivalis while promoting fimbrial production.
Metabolic and proteomic analyses of P. gingivalis responses to pABA showed that P.
gingivalis can utilize pABA for folate biosynthesis. Surprisingly, pABA reduced the
production of exopolysaccharide and attenuated the virulence of P. gingivalis. These
metabolic interactions may regulate community density and spatial configuration, again
supporting the developing narrative that metabolic communication promotes structure
and polymicrobial synergy within the oral biofilm [102]. It is important to note that
individual species of oral streptococci can affect P. gingivalis synergistically or
antagonistically through distinct process. For example, Streptococcus cristatus and
Staphylococcus intermedius are antagonistic to P. gingivalis [103, 104], in part through
removal of the biofilm-promoting amino acid arginine by streptococcal arginine
deiminase enzymes [103].
T. denticola and P. gingivalis Metabolic Interactions
Most of the examples discussed so far involve early colonizing commensal bacteria
and more pathogenic later colonizers; however, interactions among these secondary
colonizers are also manifold [105]. One example of cooperative metabolism between
17

periodontal pathogens is the metabolic cross-talk between Treponema denticola and P.
gingivalis. When cultured together, P. gingivalis and T. denticola coaggregate and display
enhanced growth [106-108]. Gas-liquid chromatography analysis of culture supernatants
demonstrated that P. gingivalis produces isobutyric acid, which stimulates the growth of
T. denticola, while T. denticola secretes succinate, which is utilized by P. gingivalis [106].
Additional studies demonstrated that T. denticola induces the production and secretion
of glycine by P. gingivalis to promote its own growth in mixed culture [107].
Transcriptome analysis also suggests that P. gingivalis produces thiamine pyrophosphate,
an essential nutrient for T. denticola; however, direct cross-feeding of this metabolite has
yet to be established. Recently, in vivo metatranscriptomic studies showed that these
cooperative metabolic interactions occur during periodontitis and may be a significant
contributor to synergistic pathogenicity [109, 110].
Polymicrobial Synergy and Dysbiosis in Cancer
One current theory of periodontal disease etiology, the polymicrobial synergy and
dysbiosis (PSD) model, holds that synergistic interactions within the polymicrobial
community shape and stabilize a dysbiotic microbiota which perturbs host homeostasis.
Disease is caused by reciprocally reinforced interactions between such physically and
metabolically integrated polymicrobial communities and a dysregulated host
inflammatory response [102]. While periodontitis and cancer are clearly distinct diseases,
they share an underlying similarity in that they are, in essence, wounds that fail to heal
[111]. Community perturbations consistent with a PSD model have been proposed for
tumor development [112, 113]. Combinations of oral bacterial species are consistently
18

identified in OSCC lesions, resonating with the idea that community-wide properties may
promote tumorigenesis.
In the 4NQO model, F. nucleatum and P. gingivalis synergistically promote cancer
progression [60]. Another feature of the PSD model is that the microbial roster is of less
relevance to nososymbiocity than the presence of combinations of functional genes, as
communities of different compositions can exhibit similar functions [102]. Support for
this concept in OSCC comes from a study of the microbiota and transcriptome in the
4NQO mouse model. Whereas variability in community dynamics was observed, the
metatranscriptome revealed patterns of metabolic signatures consistently present in
OSCC. These include nitrogen transport, response to stress, interspecies interactions,
Wnt pathway modulation, and amino acid and lipid biosynthesis [62]. Similarly, a pilot
study of human OSCC tumors found metabolic activities better correlated with disease
than did community microbial composition [114], and a comparison of microbiotas
associated with OSCC in different countries reveals functional rather than compositional
similarities [115]. Fig. 3 summarizes a proposed role for PSD in OSCC.
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Figure 3: Schematic representation of polymicrobial synergy and dysbiosis model for oral
squamous cell carcinoma. In health, host cell responses to homeostatic communities are
a eubiotic balance of proliferation with programmed cell death. Driver mutations lead to
dysregulation of host processes, which can also be manipulated by organisms associated
with a dysbiotic community. As the tumor microenvironment is established anaerobic,
gram-negative organisms are enriched as a result of hypoxic, pro-inflammatory
conditions. As organisms such as P. gingivalis, F. nucleatum and T. denticola accumulate,
the tumor cells can acquire an invasive phenotype through EMT, as well as increased
resistance to chemotherapeutic drugs.
Interactions among bacterial constituents of communities can be antagonistic as
well as synergistic, and numerous cases of antagonisms have been documented among
oral bacteria [38, 102, 116] Although there are conflicting reports in the literature [117],
in general, most oral streptococcal species tend to be underrepresented in the
microbiotas associated with OSCC [62, 118]. This can be interpreted to indicate reduced
fitness of these organisms in a tumorigenic environment.
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However, a further

interpretation is that these organisms are eubiotic and help maintain homeostasis at
mucosal membranes; in their absence the microbiota becomes increasingly tumorigenic.
In that regard, S. gordonii can reprogram epithelial cell global transcriptional patterns
such that the subsequent response to P. gingivalis is diminished, and, further, S. gordonii
can prevent P. gingivalis-induced gingival epithelial cell proliferation [102]. Moreover, S.
gordonii can antagonize P. gingivalis-induced ZEB2 production and associated cell
migration by inhibiting the activation of the FOXO1 transcription factor through the TAK1NLK negative regulatory pathway, as shown in Fig. 4 [38]. Hence, while S. gordonii is an
accessory pathogen in periodontal disease [102], this species may be a homeostatic
commensal in oral cancer, an illustration of the importance of environmental context for
bacterial functionality.
The goal of this study was to identify signaling events manipulated by periodontal
pathogen P. gingivalis that contribute to homeostatic disruption, specifically focusing on
pathways overridden by homeostatic commensal S. gordonii in gingival epithelial cells.
We hypothesized that P. gingivalis would activate genes involved in tissue disruption and
dampen innate immune signaling, whereas S. gordonii would either program the cells to
resist this activation or interact with other inhibitory pathways. We characterized the
differences in transcriptomic responses of epithelial cells challenged with P.
gingivalis and/or S. gordonii using RNAseq. The transcriptome data revealed OLFM4, a
gene involved in apoptosis, proliferation, migration, and dysregulation of innate
immunity, all of which are differentially influenced by the microbes, as a potential axis
that is disturbed by P. gingivalis and restored by S. gordonii. The initial identification of
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OLFM4 was followed by characterization of the mechanism for upregulation by P.
gingivalis, inhibition by S. gordonii, and ultimately the phenotypic outcome of this
differential regulation.

Figure 4: Antagonistic interactions of S. gordonii on P. gingivalis through activation of the
TAK1-NLK host kinase cascade. P. gingivalis can dephosphorylate FOXO1 on serine
residues which prevents translocation form the nucleus to the cytoplasm thus enhancing
activity. When S. gordonii is present the TAK1-NLK1 pathway is activated which
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supersedes the effect of P. gingivalis and increases phosphorylation of FOXO1 on Ser329
thus allowing translocation of FOXO1 to the cytoplasm where it is inactive.
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CHAPTER 2 MATERIALS AND METHODS
Eukaryotic Cells, Bacterial Strains, Growth and Infection Conditions. Telomerase
immortalized gingival keratinocytes (TIGKs) [119] and OKF6/TERT2 cells [120] were
maintained with Dermalife-K Serum free culture medium supplemented with DermaLife
K LifeFactors Kit. SCC9 cells from ATCC were grown in 1:1 DMEM: Ham’s F12 medium
supplemented with 400 ng/ml hydrocortisone and 10% fetal bovine serum. ESCC9706
cells [121] were grown using DMEM supplemented with 10% fetal bovine serum. Cells
were cultured at 37°C with 5% CO2. Porphyromonas gingivalis ATCC 33277, HG66, W83,
381, A1A7-28, and low passage clinical isolate MP4-504 were grown in trypticase soy
broth (TSB) supplemented with 1 mg/mL yeast extract, 5 μg/mL hemin and 1 ug/mL
menadione. Deletional mutants ΔfimA, Δmfa1, ΔserB, and ΔporK [57, 122-124] were
grown in the presence of 10 μg/mL erythromycin, Δkgp was grown in the presence of 20
ug/mL chloramphenicol, Δltp1/Δphp1 and ΔrgpA/B were grown in the presence of
erythromycin and 1ug/mL tetracycline, and Δkgp/rgpA/B were grown in the presence of
erythromycin, tetracycline, and chloramphenicol [125]. Streptococcus gordonii DL1, S.
mutans KSPK2, S. oralis 10557, S. constellatus ATCC 27823, and S. sanguinis 10556 were
grown in brain heart infusion broth (BHI) supplemented with 5 mg/ml yeast extract, S.
gordonii ΔspxB CΔspxB, ΔsspA/B, Δcbe, [100] were grown in the presence of 5 µg/mL
erythromycin, and CΔspxB was grown with 10 µg/mL tetracycline. Fusobacterium
nucleatum ATCC 25586 was grown in BHI supplemented with 1 mg/mL yeast extract, 5
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μg/mL hemin, and 1 μg/mL menadione. Treponema denticola ATCC 35405 was grown in
new oral spirochete broth (NOS), and Filifactor alocis ATCC 35896 was grown in BHI
supplemented with 5 mg/mL yeast extract, 5 μg/mL hemin, 1 μg/mL menadione, and 20%
L- arginine. All bacteria were grown to mid-log phase at 37°C under standard anaerobic
conditions of 85% N2, 10% H2, 5% CO2.

Cells were grown to ~80% confluence and challenged with bacteria at an MOI of 100 for
1 h, followed by 23 h culture in fresh medium, unless otherwise noted.

Antibodies and Reagents
OLFM4, Activated Notch1, and GAPDH antibodies were from Abcam. Phalloidin- Texas
Red, Alexa Fluor 488, and DAPI were from Thermofisher. OLFM4 and Notch1 ELISAs were
from Abcam, and Jagged1 ELISA was from Thermofisher. OLFM4, Notch1, Notch2, Notch3,
Notch4, Jagged1, Jagged2, DLL1, DLL3, DLL4, SMAD3, SMAD7, ZEB2, FOXO1, β-catenin,
GSK3β, ADAM10, ADAM17, and NLK siRNA were from Origene. TLCK, FH535, and
chromogenic substrate L-BAPNA were from Sigma Aldrich. Recombinant chimera
Jagged1-FC was from RND systems. Gamma secretase inhibitor LY-374973 (DAPT) was
from Sigma Aldrich, and ADAM/TACE inhibitor TAPI-2 was from Tocris.

Quantitative Reverse Transcription-PCR
Cells were harvested, and RNA was purified using RNAeasy plus kit from Qiagen. 2ug RNA
was reverse transcribed using high capacity reverse transcription kit (Thermofisher).
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Applied Biosystems Taqman fast universal master mix and Taqman gene expression
assays for OLFM4, GAPDH, HES5, Notch1, Notch2, Notch3, Notch4, Jagged1, Jagged2,
DLL1, DLL3, DLL4, SMAD3, SMAD7, ZEB2, FOXO1, β-catenin, GSK3β, ADAM10, ADAM17,
and NLK were from Thermofisher. qRT-PCR was performed using an Applied Biosystems
QuantStudio 3. Thresholds were automatically calculated using Applied Biosystems
software, and Cycle threshold (Ct) values were normalized to GAPDH. Fold changes were
calculated using 2-(delta delta)Ct.

Immunoblots and ELISAs
Cells were lysed using RIPA buffer containing Protease and PhosSTOP phosphatase
inhibitor (Roche). Protein concentration was estimated by a bicinchoninic acid (BCA)
assay. Proteins (20 μg) were separated on a 10% SDS-PAGE gel, and transferred to a
nitrocellulose membrane (0.2 μm) by electroblotting for 1h at 100V. Nitrocellulose
membranes were blocked with 5% bovine serum albumin (BSA) in Tris buffered saline
with 0.1% Tween 20 (TBST) for 1 h at room temperature. The membrane was probed with
primary antibodies in TBST overnight at 40C. Membranes were washed 3 times with TBST,
and probed with HRP-conjugated secondary antibody at room temperature for 1 h. ECL
substrate (ThermoFisher) was used to visualize the proteins, and images were generated
using a ChemiDoc XRS Plus (BioRad).
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Cell culture supernatant was centrifuged for 20 min at 20,000xg at 40C, filtered (0.4 μm),
and concentrated using Amicon Ultra concentrators. For ELISA, 25 μl of supernatant per
well was used per manufacturer’s guidelines.

Plasmid preparation, RNA interference, Transfections, and Luciferase assay
OLFM4 promoter-luciferase reporter construct was made by amplification of a 500 bp
fragment upstream of the OLFM4 coding sequence, which was cloned into pGL3-basic
plasmid (Promega). All constructs were confirmed by sequencing at the University of
Louisville Sequencing Core. The internal control reporter was pRL vector that provides
constitutive expression of Renilla luciferase (Promega). For siRNA cells were grown to 5060% confluence, and cells for plasmid transfection were grown to 60-70% confluence.
Transfection was for 48 h using Lipojet transfection agent (SignaGen), and after 24h
medium was changed to allow cells to recover before bacterial challenge. Confirmations
of knockdowns can be found in Fig. S1. Luciferase reporter assays were performed using
a Stop & Glo Dual luciferase reporter kit from Promega. Luciferase activity was measured
using a 10s integration time in a Luminometer (Molecular Devices). Firefly luciferase
activity was normalized to Renilla luciferase activity from the same lysates.
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Figure S1: Confirmation of siRNA transfections. Target genes for qRT-PCR were
normalized to GAPDH, and fold changes were calculated using the ΔΔCT method.
Significance was calculated using a One-way ANOVA, and *** P<.005 and **** P<.001.
Immunofluorescence and Confocal Laser Scanning Microscopy
TIGK cells were grown on Lab-Tek II chamber slides, and after bacterial challenge cells
were washed twice with phosphate buffered saline (PBS), fixed and permeabilized with
4% paraformaldehyde and 0.1% Triton x-100 for 10 min at room temperature. Goat serum
(10%) in TBST was used to block the cells for 20 min at room temperature. Cells were
incubated with primary antibody in TBST with 10% goat serum overnight at 4OC. Cells
were washed 3 times with TBST, then incubated with Alexa Fluor 488 secondary antibody
(1:200) for 2 h at room temperature in the dark. After washing as before and blocking
with 10% goat serum, cells were incubated with Texas Red-Phalloidin (1:100) for 2 h at
room temperature in the dark. Cells were washed 3 times, and coverslips were mounted
using ProLong Gold (Invitrogen) with 4’6-diamidino-2-phenylindole (DAPI) overnight.
Slides were scanned with a Leica SP8 confocal microscope, and images were analyzed
with Volocity 6.3 Software (PerkinElmer).

Nuclear localization was quantified using the 3D image processing software IMARIS
(Bitplane AG). The Surfaces function in IMARIS was used to create a 3D model of the
nuclei from the DAPI channel. IMARIS surfaces then calculated Alexa Fluor 488 voxels
within each nucleus, which was normalized to the volume of the nucleus.
normalized Alexa Fluor 488 was then divided by the number of cells analyzed.
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Total

Transwell Assays
For studying bacterial interactions with the epithelial cells, 1x105 cells were grown only in
the lower chamber of a 0.4 μm transwell filter plate. Cells were challenged with P.
gingivalis, and the upper chamber contained cell culture media and either S. gordonii, S.
mutans, or S. oralis.

For studying epithelial cell to epithelial cell interactions, TIGKs were cultured in both the
lower chamber and on the transwell insert in the upper chamber. P. gingivalis was added
to the upper chamber only.

To measure the motility of TIGK cells we used a matrigel migration assay (BD Biosciences).
Cells (2x105) cells were seeded onto the matrigel insert in the upper chamber, with cell
culture medium in the lower chamber, and cultured for 18 h. The filter was removed, and
the surface was scraped with a cotton swab to remove any cells that did not migrate. Cells
that migrated through the filter were fixed with 1% methanol, and stained with toluidine
blue. Cells were counted from 3 random fields at 20x using a Nikon Eclipse T100
microscope.

RNAseq
RNA was extracted using the RNAqueous-Micro Total RNA Isolation kit (ThermoFisher).
The TruSeq Stranded Total RNA with RiboZero Plus kit (Illumina) was used to generate a
sequencing library from 1 µg of total RNA. Paired-end sequencing was performed on an
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Illumina Nextseq 500 at the University of Louisville Core using the Nextseq 500 HighOutput Kit (150 cycles) (Illumina). Base calls were made using the BaseSpace FastQ
Version 1.0.0 application (Illumina, Inc.). Raw gene counts with a minimum of two counts
per million in at least one sample were used as the initial dataset for downstream RNASeq
analyses. These raw counts were used for the determination of differentially expressed
genes via the DESeq2 Bioconductor/R package (DOI: 10.18129/B9.bioc.DESeq2) using the
recommended guidelines. Output was in the form of log2 fold change expression values
and p-values adjusted for multiple comparisons using the Benjamini-Hochberg procedure.
Differentially expressed genes were defined using cutoffs of 1 for the log2 fold change
and an adjusted p-value of 0.05. This output was used as input for the generation of
volcano

plots

using

the

EnhancedVolcano

Bioconductor/R

package

(DOI:

10.18129/B9.bioc.EnhancedVolcano). This output was also used as input for functional
enrichment analysis through the String Database version 11 using an FDR stringency of 1
percent and a minimum interaction confidence score of 0.400 for network generation.
For principal component analysis (PCA) and heatmap generation, the raw count data were
made homoscedastic using a regularized logarithm transformation. PCA was conducted
using base R and PCA plots generated using the ggfortify R package. Gene count data for
heatmap generation was further converted into z-scores and used as input into the
ComplexHeatmap Bioconductor/R package.

Gingipain Activity Assay
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Culture supernatant from P. gingivalis was filtered (0.4 μm) and combined with filtered
supernatant from with either aerobic or anaerobic cultures of S. gordonii or S. mutans.
For experiments using H2O2, culture supernatant from P. gingivalis was incubated with
H2O2 for 30 min. Gingipain activity was visualized using the chromogenic substrate LBAPNA. The rate of substrate hydrolysis and the accumulation of p-nitroanilide were
monitored spectrophotometrically at 405 nm over time in a Spectramax M5 reader
(Molecular Devices).

Statistical Analysis
Each analysis is representative of at least 3 biological replicates with technical duplicates,
and confocal images are representative of 3 biological replicates with at least 3 randomly
scanned areas of the chamberslide. ANOVA with Tukey’s multiple comparison test were
conducted using GraphPad Prism V8. Statistical analyses of RNA-Seq data are described
above.
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CHAPTER 3 RESULTS
To characterize the interplay between P. gingivalis and S. gordonii at the epithelial
barrier we first employed RNAseq to identify host genes that are differentially regulated
in the presence of each organism alone versus the two species present together.
Telomerase immortalized gingival keratinocytes (TIGKs) were challenged with either P.
gingivalis, S. gordonii, or a dual infection with both organisms. Fig. 5A shows the PCA plot
for the RNAseq, where we observed tight clustering of samples within the same group
and separation between each of the groups, indicating distinct transcriptional responses.
We enriched for genes involved in Notch signaling in Fig. 5B, which was recently shown
to be activated by P. gingivalis [42]. We found in Fig. 5B that the Notch1 and Notch3
receptors, Jagged1 ligand (Jag1), and downstream targets OLFM4 and Hes5 were all
upregulated by P. gingivalis.
OLFM4 is an antiapoptotic glycoprotein which promotes tumor growth [43], and
is selectively expressed in inflamed epithelium [47].

In the dual infection group,

expression of all of these genes was significantly reduced compared P. gingivalis alone,
and differential expression of the Notch pathway in response to P. gingivalis (Pg) did not
occur in the presence of S. gordonii (Sg). The results for the Pg vs. NI, Pg+Sg vs. Pg, Pg+Sg
vs. Sg, and Pg vs. Sg comparisons from the RNAseq were also summarized as a volcano
plot in Fig. 5C-F, and shared differentially expressed genes summarized as upset charts in
Fig. 5G-H. The transcriptome data on P. gingivalis induction of OLFM4 was corroborated
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in a dose and time dependent manner at the transcriptional (Fig. 6A) level, and at 24 h
the protein level by Western blotting (Fig. 6B ), ELISA (Fig. 6C) and confocal microscopy
(Fig. 6D), all showed an increase in OLFM4 protein in response to P. gingivalis. These
mRNA and protein analyses identify that P. gingivalis-induced upregulation of OLFM4
through Notch signaling is reduced when S. gordonii is present.
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Figure 5: RNAseq of TIGK cells challenged with P. gingivalis and/or S. gordonii
TIGK cells were challenged with P. gingivalis (MOI 100) and/or S. gordonii (MOI 50) for 1h,
then the media was changed to remove any non-adherent bacteria. Cells were harvested
at 24h, at which point RNA was harvested, and libraries were prepared for RNAseq. The
PCA plot (A) shows distinct separation of non-infected (NI), P. gingivalis (Pg), S. gordonii
(Sg), and P. gingivalis co-challenged with S. gordonii (Pg+Sg) groups, as well as a tight
clustering of individual samples within each group. Notch signaling is transcriptionally
regulated by P. gingivalis, and S. gordonii interrupts activation by P. gingivalis, specifically
reducing Notch1, Notch3, Jagged1, Hes5, and OLFM4 (B). Graphical comparisons of gene
expression are represented by volcano plots for P. gingivalis vs. NI (C), P. gingivalis + S.
gordonii vs. P. gingivalis alone (D), P. gingivalis + S. gordonii vs. S. gordonii alone (E), and
P. gingivalis alone vs. S. gordonii alone (F). A summary of the shared upregulated (G) and
downregulated (H) genes for each comparison have been presented as upset charts.
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Figure 6: Regulation of OLFM4 by P. gingivalis
TIGK cells were challenged with P. gingivalis ATCC 33277 at an MOI of either 10, 50, or
100 for 6 h, 24 h, or 48 h, then RNA was harvested and reverse transcribed into cDNA for
qRT-PCR (A). OLFM4 upregulation was first observed at 24 h, and significantly increases
in a dose and time dependent manner. Cells were harvested as previously described at
24 h, and western blot confirmed increases OLFM4 protein expression (B). As OLFM4 is a
secreted protein, verification of increased secretion was investigated by ELISA of cell
culture supernatants. Cells were challenged with P. gingivalis at indicated MOIs, then
supernatants were collected, filtered, and concentrated (C). Cells were grown on chamber
slides and challenged for 24h at an MOI 100, then probed with OLFM4 antibodies (green),
phalloidin labeling actin (red), and lastly the nucleus was stained with DAPI (blue). P.
gingivalis significantly increased OLFM4 intensity, which was normalized to the size of
each nucleus (D). 500 bp upstream of OLFM4 was cloned into the promoterless PGL3Firefly luciferase construct, and was used to measure promoter activity of TIGK cells
challenged with P. gingivalis at an MOI of 100 for the indicated times. P. gingivalis
increases promoter activity at 6 h, with the greatest increase at 24 h (E). Multiple strains
of P. gingivalis were tested at an MOI of 100 for 24 h, including the encapsulated W83
and low passage clinical isolate MP4-504 (F). Each strain was equally able to stimulate
OLFM4 expression. P. gingivalis upregulated OLFM4 in OKF6/TERT1 cells, which are
immortalized non-cancerous mucosal cells (G), as well as the esophageal cancer derived
cell line ESCC9706 (H) and tongue squamous cell carcinoma derived SCC9 cell line (I).
Target genes for qRT-PCR were normalized to GAPDH, and fold changes were calculated
using the ΔΔCT method. Significance was calculated using a One-way ANOVA, and *P<.05,
** P< .01, *** P<.005, and **** P<.001.
To confirm regulation of OLFM4 at the transcriptional level, TIGKs were
transfected with a luciferase-reporter construct containing the regulatory fragment
spanning 500bp upstream of the coding region [126]. In a luciferase assay challenge with
P. gingivalis increased OLFM4 promoter activity beginning at 6 h (Fig. 6E). We explored
multiple P. gingivalis strains to verify upregulation of OLFM4 is a property conserved
across the species. In Fig. 6F we show all tested strains of P. gingivalis induced elevated
OLFM4 expression, including the fimbriated/non-encapsulated lineage (33277, 381, and
the gingipain hypersecreting HG66), the encapsulated/afimbrial lineage (W83), the
fimbriated/encapsulated lineage (A7A128) and the low-passage clinical isolate MP4-504
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[127-130]. Next, we determined whether OLFM4 regulation by P. gingivalis is specific to
gingival epithelial cells. The OKF6 line are telomerase immortalized buccal mucosa cells,
and we found that P. gingivalis upregulates OLFM4 in these cells, albeit to lower levels
than occur in TIGKs in Fig. 6G. Tongue (SCC9) and esophageal (ESCC9706) squamous cell
carcinoma cells also displayed an increase in OLFM4 expression in response to P.
gingivalis challenge, again at a substantially lesser magnitude compared to TIGK cells in
Fig. 6H-J. These results indicate that epithelial cells of the gingiva, which is the primary
in vivo habitat of P. gingivalis, are more responsive to challenge with the organism, at
least in terms of OLFM4 regulation, as compared to cells derived from other sites in the
oral and esophageal regions.
Because genes involved in Notch signaling and OLMF4 were coordinately
upregulated by P. gingivalis exposure, and normalized when S. gordonii was present, we
further explored the role of Notch signaling in the regulation of OLFM4 in TIGK cells. There
are four Notch receptors which initiate signaling through the pathway, and quantitative
(q) RT-PCR showed that expression of Notch1 and Notch3 is enhanced by infection with
P. gingivalis in Fig. 7A. To elucidate the role of these Notch receptors in OLFM4
upregulation, expression of each receptor was suppressed using siRNA. Knock down of
Notch1 led to significantly decreased OLFM4 mRNA levels in the P. gingivalis challenged
cells in Fig. 7B, indicative of a role for Notch1 in the signaling pathway exploited by P.
gingivalis to regulate OLFM4. Knock down of Notch 2 and 4 had no effect on OLFM4
expression, whereas knock down Notch3 significantly increased the level of OLFM4,
possibly due to increased availability or expression of Notch1. Notch signaling is activated
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by the ligands Jag1, Jag2, DLL1, DLL3, and DLL4, and by qRT-PCR P. gingivalis upregulates
expression of Jag1 and downregulates Jag2 in Fig. 7C. As shown in Fig. 7D knock down of
Jag1 led to decreased induction of OLFM4 by P. gingivalis, whereas knocking down Jag2
increased OLFM4, indicating that Jag2 expression may interfere with signaling through
Notch1. Suppression of DLL 1, 3, or 4 did not negatively influence OLFM4 mRNA levels in
response to P. gingivalis. Knock down of Notch1 and Jag1 also diminished P. gingivalisdependent regulation of an additional target of the Notch signaling pathways, Hes5 (Fig.
7E),. Collectively these data corroborate the importance of the Jag1-Notch1 signaling
pathway in TIGK responses to P. gingivalis.
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Figure 7: Regulation of Notch signaling by P. gingivalis
P. gingivalis upregulates Notch1 and Notch3 receptors, but not Notch2 and Notch4 at
MOI 100 for 24 h in TIGK cells by qRT-PCR (A). Notch1-4 receptors were individually
knocked down through siRNA transfection, and scrambled siRNA was used as a control.
P. gingivalis requires Notch1, but not Notch2-4 for OLFM4 upregulation (B). Similarly, we
investigated regulation of Notch ligands Jag1, Jag2, DLL1, DLL3, and DLL4 by P. gingivalis
as in (A) and found P. gingivalis significantly upregulates Jag1, downregulates Jag2, and
does not regulate DLL1, DLL3, and DLL4 (C). Employing siRNA transfections as in (B) for
Notch ligands we found that Jagged1 was required for OLFM4 upregulation by P.
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gingivalis, but not Jag2, DLL1, DLL3, or DLL4 (D). HES5 is also a downstream target of
Notch signaling, and in a similar fashion to OLFM4 requires Notch1 and Jag1 for optimal
regulation of HES5 mRNA (E). Target genes for qRT-PCR were normalized to GAPDH, and
fold changes were calculated using the ΔΔCT method. Significance was calculated using a
One-way ANOVA, and ** P< .01, *** P<.005, and **** P<.001.
It has been shown that endothelial cells are able to cleave Jag1 and release a soluble form
of Jag1 that can then bind to Notch receptors on colorectal cancer cells and activate
signaling [131]. To explore whether a similar mechanism of activation occurs in our model,
we utilized a transwell system to determine whether challenge with P. gingivalis causes
release of soluble signaling factors. TIGKs were cultured both on the transwell filter in the
upper chamber, as well as in the lower chamber. When cells in the upper chamber were
challenged with P. gingivalis, OLFM4 transcription was upregulated in the lower chamber
cells in Figure 8.

Figure 8: P. gingivalis induces paracrine activation of Notch signaling through soluble
Jagged1
TIGK cells were grown in the lower chamber of a 0.4um transwell plate, as well as on top
of the transwell filter. Only cells above the transwell filter were transfected with either
43

control siRNA or siJag1. Cells were then challenged with P. gingivalis either above or
below the transwell filter as indicated, and only cells below the transwell filter were
harvested for RNA and reverse transcribed for qRT-PCR. P. gingivalis alone was not
enough to stimulate the lower TIGK cells in the upper chamber of the transwell filter, but
when TIGK cells were seeded onto the upper chamber activation of OLFM4 in the lower
chamber was maintained. Additionally, specifically knocking down Jag1 reduced OLFM4
activation in the lower chamber cells, which implicates a soluble form of Jag1 being
involved in this paracrine activation mechanism. Target genes for qRT-PCR were
normalized to GAPDH, and fold changes were calculated using the ΔΔCT method.
Significance was calculated using a One-way ANOVA, and **** P<.001.
To evaluate the role of Jag1 in this regulation Jag1 was knocked down by siRNA in
cells in the upper chamber. After challenge of upper chamber cells with P. gingivalis there
was significantly less OLFM4 expression in the lower chamber cells compared to the
siControl condition as shown in Figure 8. These results indicate that P. gingivalis can
activate the Notch pathway in a paracrine manner by increasing production of Jag1.
OLFM4 is also a target gene of the Wnt/β-catenin pathway and of the NF-κB
transcription factor [126]. As P. gingivalis can activate Wnt/β-catenin signaling, but not
NF-κB [32, 57], we thus questioned whether the Wnt/β-catenin pathway is also involved
in P. gingivalis-induced expression of OLFM4.

However, neither pharmacological

inhibition of Wnt nor siRNA knockdown of β-catenin had an affect on OLFM4 induction in
response to P. gingivalis as shown in Fig. 9 A-B.
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Figure 9: Wnt/β-catenin and ZEB2 are not required for activation of OLFM4 by P. gingivalis
P. gingivalis activates Wnt/B-catenin signaling, and this pathway has been implicated in
OLFM4 regulation. We utilized siRNA targeting β-catenin (A) and a pharmacological
inhibitor of Wnt signaling, FH535 (B) in TIGK cells. Cells were then challenged with P.
gingivalis at an MOI of 100 for 24 h, and RNA was harvested for QRT-PCR. β-catenin knock
and pharmacological inhibition of Wnt signaling did not impede the regulation of OLFM4.
P. gingivalis also activates the epithelial to mesenchymal transition transcription factor
ZEB2, which could potentially bind the promoter region based on a consensus sequence
found upstream of the coding region of OLFM4. Knocking down ZEB2 did not prevent
regulation of OLFM4 by P. gingivalis (C). Target genes for qRT-PCR were normalized to
GAPDH, and fold changes were calculated using the ΔΔCT method. Significance was
calculated using a One-way ANOVA, **** P<.001.
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In silico interrogation of the promoter region of OLFM4 using the eukaryotic
promoter database, revealed the presence of a Zeb2 consensus binding element. Zeb2
activity is enhanced by P. gingivalis, hence we examined its potential involvement in
OLFM4 regulation. As shown in Fig. 9C, siRNA knock down of Zeb2 did not prevent
increased OLFM4 mRNA production in response to P. gingivalis. This finding further
supports the importance of Notch signaling in the regulation of OLFM4 by P. gingivalis.
One mechanism for transcriptional regulation of Jag1 is through the integration of
Notch and TGF-β signaling. SMAD3, a component of the TGF-β transcriptional activation
complex, has been shown to activate Notch signaling through upregulation of Jag1 and
Hey1 [132]. We show in Fig. 10 that SMAD3 is involved in P. gingivalis-induced Jag1
transcriptional regulation.

Figure 10: SMAD3 enhances upregulation of Jagged1 by P. gingivalis
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TGF-β signaling intersect at the SMAD3-Jag1 signaling axis. SMAD3 has been shown to
transcriptionally regulate Jag1, leading to activation of Notch signaling. Here we knocked
down SMAD3 with siRNA in TIGK cells, and used scrambled siRNA as a control. TIGK cells
were then challenged with P. gingivalis for 24 h, and RNA was harvested for qRT-PCR.
SMAD3 knockdown significantly reduced Jag1 transcript, which implicates TGF-β signaling
as a potential activator of Notch signaling. SMAD3 transcript was normalized to GAPDH,
and fold changes were calculated using the ΔΔCT method. Significance was calculated
using a One-way ANOVA, *** P<.005, and **** P<.001.
To identify the effector molecules of P. gingivalis responsible for activating Notch
signaling, we examined a panel of strains with mutations in established virulence or
colonization factors. As shown in Fig. 11A, loss of fimbrial adhesins or of serine and
tyrosine phosphatases did not impact the ability of P. gingivalis to regulate OLFM4. In
contrast, the ΔrgpABΔkgp mutant, which is deficient in the production of the arginine
specific (RgpA and RgpB) and lysine specific (Kgp) gingipain proteases, was unable to
stimulate OFLM4 production.
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Figure 11: Activation of Notch signaling by P. gingivalis gingipains
TIGK cells were challenged for 24 h at an MOI of 100 with ATCC 33277 wildtype (WT), as
well as deletional mutants of adhesins (mfa1, fimA), tyrosine and serine phosphatase
network (ltp1/php1, serB), and type 9 secretion system (T9SS) machinery and effectors
(porK, kgp/rgpA/rgpB). Loss of P. gingivalis adhesins or phosphatases did not interfere
with regulation of OLFM4, but loss of T9SS regulatory protein PorK and T9SS cargo
kgp/rgpA/rgpB significantly reduced levels of OLFM4 (A). We then challenged TIGK cells
with P. gingivalis wildtype treated with the gingipain inhibitor TLCK, as kgp, rgpA/B, and
kgp/rgpA/rgpB deletional mutants (B). RNA was harvested, and OLFM4 transcript
measured by qRT-PCR. TLCK treated P. gingivalis was unable to stimulate OLFM4
transcription, and an unimpaired proteolytic load was required for OLFM4 regulation. The
Notch receptors are sequentially cleaved after binding Notch ligands first by extracellular
ADAM10/17 proteases, then by intracellular gamma-secretase. TIGK cells were treated
with a pharmacological inhibitor of the extracellular ADAM10/17 proteases TAPI-2 at
indicated concentrations, then challenged with P. gingivalis for 24 h (C). Pharmacological
inhibition of ADAM10/17 (C) nor siRNA knockdown of ADAM10 and/or ADAM17 (D)
impeded P. gingivalis induced OLFM4 by qRT-PCR, implicating P. gingivalis produced
extracellular gingipain proteases in activation of Notch signaling. P. gingivalis can also
invade epithelial cells, so we also investigated the potential role of intracellular gingipains
in cleavage of intracellular Notch. Gamma-secretase inhibitor DAPT was used at indicated
concentrations, and in a dose dependent manner reduced P. gingivalis induction of
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OLFM4 in TIGK cells (E). This excludes the role of gingipains involvement of Notch
activation in an intracellular capacity. Target genes for qRT-PCR were normalized to
GAPDH, and fold changes were calculated using the ΔΔCT method. Significance was
calculated using a One-way ANOVA, ** P< .01, *** P<.005, and **** P<.001.
Gingipains are secreted through the type IX secretion system, and loss of PorK,
which is required for formation of a functional secretion pore [133] also abrogated the
ability of P. gingivalis to enhance OLFM4 transcription. We further investigated the role
of gingipains by challenging cells with individual gingipain mutants, which revealed that
loss of either Kgp or RgpA/B was sufficient to prevent upregulation of OLFM4 (Fig. 11B).
Additionally, pretreatment of parental P. gingivalis with the gingipain inhibitor TLCK
prevented OLFM4 synthesis. Engagement of the Notch receptor by Jag1 induces a
conformational change in the Notch which exposes an extracellular region of that can be
cleaved by the extracellular proteases ADAM10 and ADAM17 [134]. On the basis of
results with gingipains, we hypothesized that these proteolytic enzymes of P. gingivalis
activate signaling through cleavage of the extracellular domain of Notch. To test this
notion, we used TAPI-2, a pharmacological inhibitor of the ADAM10 and ADAM17
proteases [135]. We found that P. gingivalis remained capable of activating Notch in the
presence of TAPI-2 as shown in Fig. 11C, suggesting that the gingipains can functionally
compensate for the loss of the ADAM10 and ADAM17 proteases. This was corroborated
by siRNA targeting ADAM10 and ADAM17, which also failed to prevent activation of Notch
and upregulation of OLFM4 (Fig. 11D). In contrast, DAPT, which is an inhibitor of gamma
secretase, the enzyme that cleaves the intracellular domain of the Notch receptors,
completely inhibited stimulation of OLFM4 and HES5 transcription by P. gingivalis (Fig.
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11E). Thus, the gingipains are unable to complement cleavage of the intracellular domain
of Notch, and function extracellularly to activate Notch. Although P. gingivalis can
internalize and survive inside gingival epithelial cells [136], production of the gingipains is
downregulated intracellularly [137] and may be insufficient function on a membrane
protein. Collectively, the results show that P. gingivalis can activate Notch1 signaling in a
two-hit mechanism, by proteolytic cleavage of the extracellular domain and by increasing
production of the Jag1 agonist.
The ecosystem of the oral cavity in which P. gingivalis resides is a complex because
multispecies community partners engage P. gingivalis in multilevel interspecies
interactions, which can be either synergistic or antagonistic [102]. Hence, we next
investigated the impact of several community partners of P. gingivalis on OLFM4
regulation. Co-infection of P. gingivalis with either Filifactor alocis, Fusobacterium
nucleatum, or Treponema denticola, had no influence on regulation of OLFM4 by P.
gingivalis (Fig. 12A).
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Figure 12: Antagonism of P. gingivalis induced OLFM4 by S. gordonii
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P. gingivalis is generally found in communities, so we investigated the role these
interactions in regulation of OLFM4 in TIGK cells. Cells were challenged with an MOI of
100 of either P. gingivalis and/or Filifactor alocis (Fa), Fusobacterium nucleatum (Fn),
Treponema denticola (Td), and Streptococcus gordonii (Sg). Regulation of OLFM4 was
unaffected by Fa, Fn, or Td, but S. gordonii significantly reduced OLFM4 regulation by P.
gingivalis (A). We also investigated the role of multispecies interactions by challenging
TIGK cells with Pg (MOI 50), Fn (MOI 50), and Sg (MOI 10), and found that Sg maintained
the ability to inhibit OLFM4 (B). Confirmation of protein expression was verified by using
either cell lysates (C) or supernatants (D) with an OLFM4 ELISA. P. gingivalis significantly
increased protein expression in both cell lysates and supernatants, and S. gordonii
significantly reduced OLFM4 protein in both cell lysates and supernatants in combination
with P. gingivalis. Activated Notch localizes to the nucleus, so we then investigated
localization of Notch1 with P. gingivalis and/or S. gordonii (E). P. gingivalis significantly
increased localization of Notch1 to the nucleus, but S. gordonii prevented activation and
localization of Notch (F). We then investigated the role of other potential oral streptococci
in manipulation of P. gingivalis signaling. We found that organisms that produce H2O2 i.e.
S. gordonii, S. oralis, and S. sanguinis significantly reduced P. gingivalis mediated OLFM4
upregulation, whereas Streptococci that are unable to produce H2O2 showed a reduced
ability to inhibit OLFM4 (G). Target genes for qRT-PCR were normalized to GAPDH, and
fold changes were calculated using the ΔΔCT method. Significance was calculated using a
One-way ANOVA, *** P<.005, and **** P<.001.
However, co-infection with S. gordonii impeded OLFM4 induction by P. gingivalis,
and in a three species consortium of P. gingivalis, F. nucleatum and S. gordonii, the
antagonistic effect of S. gordonii was dominant (Fig. 12B). We verified OLFM4 expression
changes at the protein level using an ELISA, which showed that S. gordonii can antagonize
production of OLFM4 as reflected both the intracellular and extracellular amounts of the
protein (Fig. 12C-D).
Following cleavage by (gamma)-secretase the intracellular domain of the Notch
receptor localizes to the nucleus, where it binds and activates the transcription factor
RBP-JK, leading to upregulation of Notch target genes. We utilized confocal microscopy
to determine the localization pattern of cleaved Notch in TIGK cells challenged with P.
gingivalis and/or S. gordonii. Fig. 12E-F shows that P. gingivalis induces nuclear
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localization of Notch, which is antagonized in the presence of S. gordonii. These results
suggest that S. gordonii prevents P. gingivalis-induced upregulation of OLFM4 by blocking
activation of Notch signaling. S. gordonii is one of several species of oral streptococci with
the potential to coaggregate with P. gingivalis in vivo. A number of additional oral
streptococcal species were thus tested for antagonistic properties, and we found that S.
oralis and S. sanguinis were also capable of inhibiting OLFM4 expression (Fig. 12G). In
contrast, S. constellatus and S. mutans did not suppress P. gingivalis-induction OLFM4
upregulation. One phenotypic property of these streptococcal species which tracks with
antagonism of P. gingivalis, is production of hydrogen peroxide (H2O2) as a metabolic by
product [138, 139].
We have previously shown that S. gordonii can antagonize the action of P.
gingivalis by activating Nemo-like Kinase (NLK) which in turn suppresses the FOXO1
pathway. We confirmed that the antagonistic action of S. gordonii is independent of NLK
by siRNA knockdown. As shown in Fig. 13, a reduction in NLK levels did not impact the
ability of S. gordonii to prevent P. gingivalis induction of OLFM4. Additionally, we
investigated the role of exogenous Jag1 in the role of OLFM4 transcriptionally activation,
and determined whether S. gordonii could prevent activation through host cell
manipulation. Exogenous treatment with recombinant Jag1 was enough to stimulate
OLFM4 transcription (Fig. 14), however S. gordonii was unable to impede this activation,
which indicates this inhibition could be driven through P. gingivalis-S.gordonii signaling,
rather than S. gordonii-host signaling.
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Figure 13: NLK-FOXO1 signaling is not required for inhibition of OLFM4
S. gordonii inhibits manipulation of host signaling by P. gingivalis through activation of
host kinase NLK, which then phosphorylates and inactivates transcription factor Foxo1
(activated by P. gingivalis). TIGK cells were transfected with siRNA targeting NLK, then
challenged with P. gingivalis (MOI 100) and/or S. gordonii (MOI 50) for 24h. RNA was then
harvested, and expression of OLFM4 measured by qRT-PCR. Knocking down NLK had no
effect on OLFM4 inhibition by S. gordonii. OLFM4 was normalized to GAPDH, and fold
changes were calculated using the ΔΔCT method. Significance was calculated using a Oneway ANOVA, *** P<.005, and **** P<.001.
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Figure 14: S. gordonii cannot inhibit Notch signaling activated with exogenous Jagged1
TIGK cells were seeded on wells either coated with protein G or Jag1-FC, then at 24h
challenged with S. gordonii. Exogenous Jag1 was enough to stimulate OLFM4
transcription, however S. gordonii was unable to impede this activation. OLFM4 CT values
were normalized to GAPDH, and fold changes were calculated using the ΔΔCT method.
Significance was calculated using a One-way ANOVA, ** P< .01
To test whether secreted metabolites were sufficient to inhibit OLFM4 expression,
we utilized a transwell assay. TIGK cells in the lower chamber were challenged with P.
gingivalis in the lower chamber along with either S. gordonii, S. oralis, or S. mutans in the
upper chamber. Both S. gordonii and S. oralis were able to inhibit P. gingivalis-induced
OLFM4 expression whereas S. mutans had no effect (Fig. 15A). These results show that
functional activity resides in a product secreted from S. gordonii and S. oralis.
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Figure 15: Inhibition of gingipains by Streptococci produced H2O2
To follow up the role of H2O2 in the inhibition of OLFM4 by P. gingivalis we utilized the 0.4
um transwell system. TIGK cells were grown in the lower chamber, then challenged with
P. gingivalis (MOI 100) in the lower chamber where indicated and S. gordonii (Sg), S. oralis
(So), or S. mutans (Sm) in the upper chamber (A). S. gordonii and S. oralis were able to
inhibit OLFM4 independent of contact with either P. gingivalis or TIGK cells, and S. mutans
did not affect P. gingivalis induced OLFM4. S. gordonii interacts with P. gingivalis through
direct binding with adhesins (SspA/B), as well as through secreted metabolites pABA and
H2O2. Inhibition of OLFM4 expression by P. gingivalis was not ameliorated with adhesin
or pABA secretion deficient mutants (sspA/B, cbe), however the H2O2 deficient mutant
(spxB) showed significantly less inhibition. This inhibition was restored by complementing
spxB (B). The role of secreted H2O2 was confirmed by utilizing 0.4um transwell filters. TIGK
cells were grown in the lower chamber, then challenged with P. gingivalis in the lower
chamber or the indicated strains of S. gordonii in the upper chamber. The deletional spxB
mutant was unable to inhibit OLFM4, whereas the complemented strain was partially
restored to wildtype level inhibition (C). Gingipains require a reduced environment for
optimal protease activity, so we investigated the role of H2O2 in oxidizing and therefore
inhibiting activity of RgpA/B using a chromogenic substrate assay. Supernatant was taken
from P. gingivalis grown to mid-log phase by spinning the cells down and filtering the
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supernatant. P. gingivalis supernatant was then incubated with metabolically active
anaerobic or aerobic S. gordonii or S. mutans. Supernatant was then collected and
filtered, then activity of RgpA/B was measured through cleavage of a chromogenic
substrate (D). Anaerobic cultures did not impact activity of RgpA/B, but aerobically grown
S. gordonii did reduce activity of RgpA/B by about 50%. This inhibition was ameliorated in
the spxB deletional mutant, and partially restored by the complemented spxB strain. S.
mutans did not inhibit RgpA/B activity in either anaerobic or aerobic cultures. We then
confirmed inhibition of RgpA/B activity by H2O2 by incubating P. gingivalis supernatant
with indicated concentrations, and measuring activity by cleavage of a chromogenic
substrate. Significant inhibition is observed at 800 μm, and activity is reduced in a dose
dependent manner until 4 mM (E). Target genes for qRT-PCR were normalized to GAPDH,
and fold changes were calculated using the ΔΔCT method. Significance was calculated
using a One-way ANOVA, and *P<.05, *** P<.005, and **** P<.001.
To provide additional evidence of a role for H2O2 we utilized a pyruvate oxidase
mutant (ΔspxB), in which H2O2 production is reduced by approximately 90% through loss
of conversion of pyruvate to acetate with H2O2 as a byproduct. As shown in Fig. 15B, the
ΔspxB mutant was unable to suppress OLFM4 transcription in a co-infection assay. In
contrast, mutants of S. gordonii unable to bind (ΔsspA/B) or accumulate (Δcbe) with P.
gingivalis retained the ability to impede the increase in OLFM4. Similarly, in a transwell
assay with P. gingivalis in the lower chamber and S. gordonii in the upper chamber, the
ΔspxB mutant had no impact on induction of OLFM4 mRNA by P. gingivalis, whereas
parental

and

complemented

ΔspxB

mutant

were

antagonistic

(Fig.

15C).

Complementation of the mutation with the spxB gene in trans (CΔspxB) restored the
antagonistic phenotype. Collectively, these results strongly implicate secreted H2O2 as the
effector of streptococcal antagonism of P. gingivalis-induced OLFM4 regulation.
Interestingly, gingipains require a reduced environment for activity to maintain
the cysteine catalytic domain [140]. Thus, we hypothesized that oxidation by H2O2 was
impairing the activity of the gingipains. To test this, we used a chromogenic assay to
57

measure gingipain activity in the supernatant of P. gingivalis cultures incubated with
streptococci either capable or unable to produce H2O2 (Fig. 15D). Aerobically cultured S.
gordonii WT and the complemented mutant CΔspxB significantly reduced gingipain
activity. Activity was partially reduced by the ΔspxB mutant, possibly due to residual H2O2
production, and was unaffected by S. mutans. In contrast, following anaerobic culture of
the streptococcal strains, in which H2O2 is not produced, there was no inhibition of
gingipain activity in any condition. We then sought to test concentrations of H2O2 that
could inhibit gingipain activity. As shown in Fig. 15E, 800 μM was the lowest dose at which
significant inhibition of gingipain activity was observed, with the greater reduction
occurring between 1-2 mM, which is the range of H2O2 amounts that can be produced
extracellularly by streptococci [141]. Taken together, our data support the concept that
H2O2 produced by certain species of oral streptococci such as S. gordonii inhibit the
activity of gingipains and consequently impede activation of the Notch pathway by P.
gingivalis.
Many of the epithelial cell responses to P. gingivalis revolve around the axis of
survival/proliferation/migration [12]. OLFM4 is an antiapoptotic factor that promotes
tumor growth [43]. Thus, we next investigated the extent to which OLFM4 participates
in epithelial cell responses to P. gingivalis by knocking down OLFM4 and performing RNA
Seq. The PCA plot for this RNA seq showed clustering of individual biological replicates in
each group, as well as distinct separation between conditions (Fig. 16A).
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Figure 16: Knocking down OLFM4 reveals altered inflammatory transcriptomic profile
TIGK cells were transfected with either scrambled siRNA or siOLFM4, then challenged
with P. gingivalis for 24h. Libraries were prepped as described in Figure 5. The PCA plot
(A) shows tight clustering of individual samples within groups, and distinct clustering of
each group. A heatmap of pro-inflammatory cytokines/chemokines reveals significantly
upregulated pro-inflammatory markers in the siOLFM4 Pg group compared to the
siControl Pg group (B). (C) shows a volcano plot that graphically depicts differential gene
expression in siOLFM4 Pg and siControl Pg cells, and (D) summarizes the comparison of
each individual group for upregulated and down regulated genes.
Enrichment for pro-inflammatory gene within each group in Fig. 16B revealed a
distinct signature in the siOLFM4 conditions, specifically genes that were are known to be
downregulated by P. gingivalis were upregulated, including CXCL8, CXCL10, and CXCL11.
We have summarized the transcriptional changes in the siOLFM4 P. gingivalis treated cells
and siControl P. gingivalis treated cells as a volcano plot in Fig. 16C and shared
differentially expressed genes are summarized as upset charts in Fig. 16D.
OLFM4 manipulates multiple host processes through protein-protein interactions
that P. gingivalis is also known to impact, such as migration. We investigated the role for
OLFM4 in migration of the epithelial cells. In Fig. 17, we knocked down OLFM4 in epithelial
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cells, then challenged with P. gingivalis. We found that reduction of OLFM4 significantly
diminished migration of TIGKs in response to P. gingivalis. .

Figure 17: P. gingivalis promotes migration of epithelial cells through OLFM4
TIGK cells were transfected with either scrambled siRNA or siRNA targeting OLFM4. 48 h
after transfection cells were challenged with an MOI of 100 P. gingivalis, then seeded over
a Matrigel transwell insert for 18h. After incubation cells were scraped off the surface of
the membrane, and the cells that had invaded were fixed with methanol and stained with
toluidine blue. Cells were enumerated in at least 3 fields, and percentages calculated in
comparison to an insert without Matrigel coating. Significance was calculated using a
One-way ANOVA, *** P<.005, and **** P<.001.
The regulatory mechanism for OLFM4 by P. gingivalis, as well as the method for
antagonism by S. gordonii is summarized in Figure 18.
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Figure 18: Graphic summarizing the pathway by which P. gingivalis activates Notch
signaling, and OLFM4 as a downstream target of activation. S. gordonii inhibits this
activation through secretion of H2O2, which inhibits RgpA/B activity, preventing activation
and downstream activation of OLFM4.
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CHAPTER 4 DISCUSSION
The idea of bacteria causing cancer has been fervently studied since the
classification of Helicobacter pylori as a causative agent for stomach cancer in 1984. Oral
squamous cell carcinoma has a 5-year mortality rate of approximately 50%, in part
because diagnosis tends to be elusive due to its asymptomatic progression. Identification
of microorganisms, or a microbial profile, that increases the probability of OSCC would
help in identifying those who are high risk, and would represent a unique preventative
treatment modality. One candidate bacterium that has been associated with OSCC for
decades is P. gingivalis, which has the capacity to inhibit apoptosis, enhance proliferation,
and induce an epithelial-to-mesenchymal like invasive phenotype in epithelial cells. P.
gingivalis has been characterized as a keystone pathogen for periodontal disease by its
ability to directly manipulate the immune response through its own virulence factors, as
well as by driving changes in the microbial community that leads to a dysbiotic
relationship with the host immune system, leading to persistent inflammation. This
changing microenvironment can be a driving force in the transformation of epithelial cells,
as byproducts of inflammation produces a nutrient rich environment and dysregulates
the tumor immune microenvironment, which favors persistent colonization by
anaerobes. Recent studies have focused on relative abundance of bacteria on sites of
OSCC compared to contralateral healthy controls and have reported that numbers of
periodontal pathogens like P. gingivalis tend to be higher, whereas commensals such as
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some streptococci tend to be decreased [142] . While this likely reflects fitness within the
tumor microenvironment, in the absence of homeostatic commensals such as S. gordonii,
the tumorigenic potential of P. gingivalis will be unconstrained. For example, P. gingivalis
regulates EMT factor ZEB2 through dephosphorylation of host transcription factor FoxO1.
This interaction is antagonized by S. gordonii which induces phosphorylation of FOXO1
through activation of host TAK/NLK kinase cascade. These properties are made more
interesting because these organisms interact directly to enhance each other’s virulence
through attachment and metabolic synergy. However, in the host epithelial environment,
these organisms antagonize one another through dysregulation of host signaling
cascades.
The goal of this study was to identify signaling events impacted by periodontal
pathogen P. gingivalis that contribute to homeostatic disruption, specifically focusing on
pathways overridden by homeostatic commensal S. gordonii in gingival epithelial cells.
We hypothesized that P. gingivalis would activate genes involved in tissue disruption and
dampening of innate immune signaling, whereas S. gordonii would either program the
cells to resist this activation or interact with other inhibitory pathways. We approached
this by characterizing differences in transcriptomic responses of epithelial cells challenged
with P. gingivalis and/or S. gordonii using RNAseq, revealing OLFM4, a gene involved in
apoptosis, proliferation, migration, and dysregulation of innate immunity, all of which are
differentially influenced by the microbes, as a potential axis that is disturbed by P.
gingivalis and restored by S. gordonii. The initial identification of OLFM4 was followed by

64

characterization of the mechanism for upregulation by P. gingivalis, inhibition by S.
gordonii, and ultimately the phenotypic outcome of this differential regulation.
Currently, there are few studies that characterize the complete transcriptional
fingerprint left by oral microbes on gingival epithelial cells. Hasegawa et. al. focused on
transcriptional changes using a microarray of epithelial cells challenged with either F.
nucleatum or S. gordonii, which identified activation of MAPK signaling by both organisms
[143]. However, they reported that F. nucleatum increased IL-6 and IL-8 production,
whereas S. gordonii inhibited production of both. Handfield et. al. focused on the
individual

challenge

of

epithelial

cells

with

either

P.

gingivalis

or

A.

actinomycetemcomitans [23]. This report showed that P. gingivalis activated p53
signaling, leading to inhibition of apoptosis, whereas A. actinomycetemcomitans
inactivated p53 signaling, thereby inducing apoptosis [23]. Using gene array analysis in
human immortalized gingival keratinocytes (HIGKs), Mans et. al. [144] reported that S.
gordonii overrides transcriptional changes in cell cycle regulatory genes, opposing P.
gingivalis mediated cell cycle progression in favor of cell cycle arrest. While this study
provided significant insight into the regulatory mechanisms for cell cycle activity,
microarray technology has since been superseded by deep sequencing approaches, and
thus new, previously unknown targets can be identified. Additionally, as S. gordonii can
antagonize activation of transcription factor FOXO1 by P. gingivalis in gingival epithelial
cells (discussed above), there are likely to be comprehensive transcriptional changes
when P. gingivalis and S. gordonii are co-infected.
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In this study, we identified unique complete transcriptomic profiles between
gingival epithelial cells challenged with P. gingivalis and/or S. gordonii through RNAseq,
which characterized the interaction between the co-infected group to be more similar to
the individual S. gordonii group than the P. gingivalis alone group. We started by
investigating genes that were differentially regulated by P. gingivalis, but the opposite
trend was observed in the P. gingivalis + S. gordonii group. This led us to OLFM4, which
was upregulated by P. gingivalis, downregulated by S. gordonii, and was significantly
reduced compared to the P. gingivalis alone group.
OLFM4, also known as GW112, was originally characterized by its function in
binding the mitochondrial protein GRIM19 [43], and attenuating interferon-β mediated
apoptosis in prostate cancer cells [43]. OLFM4 has since been implicated in EMT, cell cycle
activity, and modulation of innate immune signaling [44, 45, 47, 126]. In non-small cell
lung cancer, under hypoxic conditions, OLFM4 is significantly upregulated, and can then
positively regulate HIF-1α to promote EMT [45]. In hepatocellular carcinoma, OLFM4
enhances activation of STAT3, which then increases proliferation and induces EMT in
HepG2 cells [145]. H. pylori induces OLFM4 regulation in gastric epithelial cells, which
upon stimulation binds NOD1/NOD2, inhibiting activation of NF-κB. Knockout OLFM4
mice could effectively eliminate H. pylori from the stomach, whereas wildtype mice
experienced persistent colonization [47]. Further investigation revealed a unique cytokine
profile in OLFM4 knockout mouse stomach, specifically increased transcriptional and
protein levels of IL-1β, IL-5, IL-12, and MIP-1α [47]. In summary, OLFM4 inhibits apoptosis,
increases proliferation and invasion, and manipulates host immune signaling, which are
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all characteristic phenotypes of epithelial cells challenged with P. gingivalis. Additionally,
S. gordonii inhibits P. gingivalis induced proliferation and invasion in epithelial cells, which
points the potential role for an OLFM4 regulatory axis.
OLFM4 is primarily regulated through the Notch1-Jagged1 signaling cascade.
Notch signaling was significantly enriched in the P. gingivalis alone RNAseq, with, for
example, Notch1, Jagged1, and the Notch target gene Hes5 were upregulated.
Interestingly, Notch1, Jagged1, and Hes5 were all significantly lower in the P. gingivalis +
S. gordonii compared to the P. gingivalis alone group. Recently, Al-Attar et. al. found that
P. gingivalis activates Notch signaling in oral mucosal and gingival epithelial cells, leading
to increased transcription, translation, and secretion of the anti-microbial protein PLA2IIA, which is one factor responsible for the dysbiotic shift observed after colonization by
P. gingivalis. We similarly observed that P. gingivalis induces nuclear localization of
Notch1 in epithelial cells. In contrast, not only does S. gordonii not induce nuclear
localization, but it inhibits Notch localization by P. gingivalis. Al-Attar et. al. found that P.
gingivalis induced nuclear localization of Notch1, whereas S. gordonii and F. nucleatum
did not. This study also revealed upregulation of HES1 and HEY1 by P. gingivalis in mucosal
cells, which is recapitulated in our epithelial cell RNAseq. Additionally, the gingipain
deficient P. gingivalis could not stimulate Notch1 in OKF6 cells. Previously, OLFM4 had
been shown to require Notch1, and stimulation with exogenous Jagged1 in order to
increase OLFM4 protein. We corroborated this finding, and additionally we excluded
Notch ligands Jagged2 and DLL1-4, as well as Notch2-4 from a role in regulating OLFM4.
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P. gingivalis produced proteolytic enzymes, the Kgp, RgpA, and RgpB gingipains,
are key virulence factors in the manipulation of host immunity and tissue homeostasis.
Each of the gingipains is capable of inhibiting classical, lectin, and alternative pathways of
the complement cascade through the proteolytic degradation of C3. The gingipains also
target C5b, which attenuates the formation of the membrane attack complex. P. gingivalis
induces non-canonical activation of β-catenin through cleavage by the gingipains into
functional fragments, which are able to translocate to the nucleus. Functional β-catenin
and gingipains are required for upregulation of ZEB2, and β-catenin is also likely involved
in the regulation of proliferation and production of MMP7. Additionally, P. gingivalis
cleaves MMP-1, -3, and -9 into their active forms with the gingipains, which leads to
increased destruction of the host periodontium and potentially increased motility of
epithelial cells. P. gingivalis induces a local chemokine paralysis through degradation of
CXCL8, CXCL9, and CXCL10, which is mediated through a secreted proteolytic enzyme
(likely the gingipains.) Additionally, the gingipains have been shown to proteolytically
degrade β-catenin into its functional form, which is capable of nuclear localization. This
proteolytic activation was capable of being induced with purified gingipains, in the
absence of any whole cell P. gingivalis whole cells. β-catenin regulates cell proliferation,
as well as MMPs, which implicates an additional role for the gingipains in these
phenotypes. P. gingivalis gingipains activate PAR2 and PAR4, leading to the
phosphorylation of IκB, the nuclear translocation of NF-κB, and increased transcription of
proMMP9 (50, 51). In addition, gingipains can cleave proMMP9, generating the mature
active enzyme (52), which is important for cancer cell invasion and metastasis. Gingipains
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can also proteolytically process proteins on the epithelial cell surface, causing release and
redistribution, with consequent effects on signal transduction and inflammatory
responses (53, 54). Intracellularly, P. gingivalis gingipains can degrade mammalian target
of rapamycin (mTOR), thus disrupting the mTOR pathway which regulates the
cytoskeleton, as well as cleave β-actin directly (55, 56). In trophoblasts, gingipains can
degrade p53 and the E3 ubiquitin protein ligase homolog protein (MDM2) and modulate
the activity of multiple signaling pathways, resulting in both cell cycle arrest and cell death
(57). The capacity of gingipains to regulate the expression of inflammatory mediators at
the mRNA level has also been demonstrated. In gingival fibroblasts, gingipains increase
TGFβ gene expression, while suppressing the expression of CXCL8 (58). Elevated signaling
through TGFβ and STAT3 could also contribute to tumorigenesis.
We found here that the gingipains are required for the activation of Notch
signaling through a previously unknown mechanism. Our data support a role for each of
the gingipains in cleaving the transmembrane protein Jagged1 into a soluble form,
allowing for paracrine activation of Notch signaling, as well as acting in place of the
extracellular ADAM10/17 proteases in cleaving Notch1 into its active form. We propose
a role for OLFM4 in the regulation of invasion in gingival epithelial cells, as well as
dampens epithelial pro-inflammatory genes, which are both functions that require
gingipains. Fig. 19 integrates OLFM4 signaling into the context of other epithelial cell
signaling pathways dysregulated by P. gingivalis.
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Figure 19: Graphic summarizing signaling pathways manipulated by P. gingivalis
While studying organisms individually reveals phenotypes specific to the
organisms, studying interactions in the context of communities provides greater
biological relevance, as it is more similar to the organization of microbes in the oral cavity.
Communities in the oral cavity tend to be complex, reducing the possibility for rogue,
individual species to interact with host cells. There are many advantages to this lifestyle,
such as protection from environmental stresses, metabolic cross-feeding, antibiotic
resistance, increased protection from immune surveillance, and an increased ability to
colonize the host through binding the biofilm substratum and community members
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through adhesins. P. gingivalis interacts with multiple bacteria in the oral cavity,
specifically F. alocis, S. gordonii, and T. denticola. A key feature for colonization is the
ability to attach to members of the community, and benefit each other through metabolic
cross-feeding. F. alocis is an emerging pathogen that is capable of localizing to gingival
epithelial cells, as well as attaching to and developing a heterotypic community with P.
gingivalis. These organisms have opposing interactions with epithelial cells, specifically in
regards to apoptosis and inflammation. Similar to F. alocis, T. denticola also interacts with
epithelial cells and P. gingivalis. T. denticola has been shown to interact with epithelial
cells through the secretion of a chymotrypsin like protease capable of degrading host
cytokines and activating MMPs. Interestingly, this protease was not sufficient to activate
Notch signaling in gingival epithelial cells, alluding to a more specific interactions being
required for Notch1 cleavage by P. gingivalis.
As a primary colonizer, S. gordonii interacts with a multitude of organisms. S.
gordonii plays a key role in the structure and regulation of pathogenicity in oral biofilms
through its secretion of H2O2. While this would normally be toxic to the anaerobic
organisms that are prevalent in periodontal diseases, there are organisms within the
biofilm that are able to detoxify H2O2, such as A. actinomycetemcomitans. A.
actinomycetemcomitans senses H2O2 through the oxygen sensitive OxyR transcriptional
regulator, which then activates catalase (KatA) and Dispersin B. Catalase detoxifies H2O2,
and Dispersin B is used to optimally distance itself from S. gordonii. Oral streptococci can
be stratified into health-associated species that produce H2O2, such as S. gordonii and S.
oralis, and cariogenic species that do not produce H2O2, such as S. mutans. S. gordonii and
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S. oralis contribute to a healthy community through H2O2 induced cell death of S. mutans
[146]. Liu et. al. characterized the production of H2O2 in a biofilm by S. gordonii,
specifically finding that H2O2 is produced at 0.7 mM-1.6 mM over a period of 2-8 h which
is sufficient to significantly impair RgpA/B activity, with inhibition starting at 0.8 mM and
maximal inhibition occurring at 2 mM. Not only does H2O2 modulate the composition of
biofilms, but it is also impacts survival and pathogenicity of other organisms. In defined
media, P. gingivalis survives in up to 3 mM of H2O2, with S. gordonii and S. oralis producing
H2O2 at about 1-2 mM. P. gingivalis has two characterized tyrosine phosphatases, which
respond differently to H2O2. Ltp1 activates the transcriptional regulator CdhR, which
inhibits mfa1 and luxS, having an overall net reduction in community development. H2O2
inhibits Ltp1 activity, inactivating CdhR, promoting mfa1 and luxS, leading to an overall
net gain in community development. Additionally, P. gingivalis controls community
development with S. gordonii through another tyrosine phosphatase Php1. Php1
positively regulates exopolysaccharide (EPS) production, which is an important feature of
biofilm substrata, acting a glue for monospecies and multispecies interactions. This
enzyme dephosphorylates Ptk1, a P. gingivalis tyrosine kinase, which is another key
regulator of EPS production and community development.
Gingipains are cysteine proteases that require a reducing environment for optimal
activity. Because H2O2 would oxidize the disulfide bonds, leading to inactivation of the
gingipains, we characterized and titrated this inhibition. Consistent with our hypothesis,
the gingipains were inactivated by the H2O2-producing S. gordonii, but not S. mutans.
This inhibition of gingipain activity is pivotal for the antagonism of Notch activation by S.
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gordonii. The communication via secreted metabolites is interesting in that there needn’t
be direct contact with the microbes to each other, or to the epithelial cells.
With an increased interest in pathogenic microorganisms, or microbial profiles,
that can act as carcinogenic agents, investigators up until now have generally overlooked
the role of commensal organisms maintaining homeostatic interactions in the host. Here
we provide additional evidence for the role of S. gordonii as a homeostatic commensal in
the context of epithelial cell transformation, whereas in periodontal disease it is
considered an accessory pathogen. This system is unique in that these organisms do not
necessarily need to be directly associated with the epithelial cells, but instead can
mediate host signaling through secreted proteases/metabolites. It’s particularly
interesting that P. gingivalis can perpetuate Notch signaling through cleavage of Jagged1,
so cells that had never interacted with P. gingivalis are able to induce Notch signaling and
OLFM4 expression. Interestingly, recent studies have found that not only is P. gingivalis
significantly enriched in OSCC, but Streptococci are significantly underrepresented under
the same conditions. This study provides insight on the complex molecular dialogue
between the commensals and pathogens of the microbiome, and particularly expands on
the role of S. gordonii through direct inactivation of P. gingivalis secreted proteases, in
addition to the previously studied subversion of host pathways to impede P. gingivalis
induced signaling.
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